SLS Hedge Fund Ownership (Q2 2026)

Sellas Life Sciences Group I (SLS)

186 + Investors. Track Smart Money conviction in SLS. See who's accumulating, reducing, or initiating positions.

Smart Money Signals — SLS

Based on 204 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 6 quarters in a row

last 6Q

For 6 consecutive quarters, more hedge funds added SLS than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

🏔️

At the ownership peak (100% of max)

100% of all-time peak

204 hedge funds hold SLS right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.

🚀

Fast accumulation — +158% more funds vs a year ago

fund count last 6Q

+125 new funds entered over the past year (+158% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.

🟢

More buyers than sellers — 71% buying

152 buying61 selling

Last quarter: 152 funds were net buyers (67 opened a brand new position + 85 added to an existing one). Only 61 were sellers (36 trimmed + 25 sold completely). A clear majority buying is a strong confirmation signal.

➡️

Steady new buyers — ~67 new funds per quarter

new funds entering per quarter

Funds opening this position for the first time: 21 → 33 → 63 → 67. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.

🔄

Mostly new holders — 58% entered in last year

■ 16% conviction (2yr+) ■ 26% medium ■ 58% new

Only 33 funds (16%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

💰

Value +494% but shares only +53% — price-driven

Value

+493%

+52%

Last quarter: the total dollar value of institutional holdings rose +494%, but actual share count only changed +53%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.

🚀

Acceleration phase — new buyers rushing in

41 → 21 → 33 → 63 → 67 new funds/Q

New funds entering each quarter: 21 → 33 → 63 → 67. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.

🌱

Early stage — 74% of holders entered in last year

■ 23% veterans ■ 3% 1-2yr ■ 74% new

Of 229 current holders: 169 (74%) entered in the past year, only 53 (23%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.

🏆

Elite ownership — 70% AUM from top-100 funds

70% from top-100 AUM funds

41 of 189 holders are among the 100 largest funds by AUM, controlling 70% of total institutional value in SLS. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

6.3

out of 10

Moderate Exit Risk

Exit risk score 6.3/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Metric	All 13F Filers (2026 Q2)	Prior (2026 Q1)	Change
Funds Holding	186	162	14.81%
13F Shares	103M	70M	48.53%
Total Value	$1.52B	$291M	423.8%
New Positions	66	63	+3
Increased Positions	83	54	+29
Closed Positions	27	17	+10
Reduced Positions	27	23	+4
Total Calls	15	10	50.0%
Total Puts	25	6	316.67%
PUT/CALL Ratio	1.67	0.6	Bearish

Metric

All 13F Filers (2026 Q2)

Prior (2026 Q1)

Change

Funds Holding

186

162

14.81%

13F Shares

103M

70M

48.53%

Total Value

$1.52B

$291M

423.8%

New Positions

Increased Positions

+29

Closed Positions

+10

Reduced Positions

Total Calls

50.0%

Total Puts

316.67%

PUT/CALL Ratio

1.67

0.6

Bearish

Institutional Holders (2026 Q2)

186 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in SLS. Verified SEC 13F-HR filings.

QUARTER:

FILTER:All New Added To Reduced No Change | Overweight >5%

Top 25 SLS holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
#	Investor	% of Portfolio	Shares	Mkt Value
1	Anson Funds Management LP	3.94%	4,500,000	$66.4M
2	Dagco, INC.	3.36%	1,232,433	$18.2M
3	Sio Capital Management, LLC	3.01%	1,230,700	$18.2M
4	Anson Funds Management LP	1.62%	1,845,900	$27.2M
5	Fulcrum Wealth Advisors, LLC	0.83%	73,253	$1.1M
6	Diadema Partners LP	0.75%	400,000	$5.9M
7	Anson Funds Management LP	0.70%	800,000	$11.8M
8	Ikarian Capital, LLC	0.56%	354,700	$5.2M
9	Instrumental Wealth, LLC	0.34%	44,914	$663K
10	Perceptive Advisors LLC	0.33%	1,500,000	$22.1M
11	Everhart Financial Group, Inc.	0.27%	288,018	$4.3M
12	Visionary Horizons, LLC	0.22%	36,000	$531K
13	Harvest Investment Services, LLC	0.22%	94,482	$1.4M
14	Diadema Partners LP	0.19%	100,000	$1.5M
15	Financial Designs Corp	0.18%	23,327	$344K
16	Martin Capital Advisors, LLP	0.18%	23,082	$341K
17	Virtus Investment Advisers, LLC	0.14%	41,788	$617K
18	Genesee Capital Advisors, LLC	0.14%	30,000	$443K
19	Millington Financial Advisors, LLC	0.13%	25,000	$330K
20	Vision Financial Markets LLC	0.13%	9,800	$145K
21	Ridgewood Investments LLC	0.12%	22,500	$332K
22	NORTHSTAR ASSET MANAGEMENT Co	0.10%	45,000	$509K
23	ELCO Management Co., LLC	0.09%	14,209	$210K
24	Scissortail Wealth Management, LLC	0.09%	31,322	$462K
25	XTX Topco Ltd	0.07%	359,090	$5.3M

Investor	Ownership History	% of Portfolio	Prev %	Rank	Conviction	Avg Buy Price	13F Score™ 3Y / 7Y	Sell Timing	Shares	Mkt Value	Change	Change %	Source	Quarter	Filed

Frequently Asked Questions — Sellas Life Sciences Group I (SLS)

What does the Smart Money Trend signal show for SLS?

Buying streak — 6 quarters in a row: For 6 consecutive quarters, more hedge funds added SLS than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for SLS?

More buyers than sellers — 71% buying: Last quarter: 152 funds were net buyers (67 opened a brand new position + 85 added to an existing one). Only 61 were sellers (36 trimmed + 25 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for SLS holders?

Elite ownership — 70% AUM from top-100 funds: 41 of 189 holders are among the 100 largest funds by AUM, controlling 70% of total institutional value in SLS. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held SLS?

Mostly new holders — 58% entered in last year: Only 33 funds (16%) have held >2 years. The majority of current holders are relatively new to the position. New holders tend to sell faster when prices drop — a shallow conviction base that could amplify any sell-off.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Market Cap	--
Enterprise Value	--
Trailing P/E	--
Forward P/E	--
PEG Ratio (5yr expected)	--
Price/Sales (ttm)	--
Price/Book (mrq)	--
Enterprise Value/Revenue	--
Enterprise Value/EBITDA	--
Beta (5Y Monthly)	--
Short Ratio (Days to Cover)	--
Short % of Float	--

Profit Margin	--
Return on Assets (ttm)	--
Return on Equity (ttm)	--

Revenue (ttm)	--
Net Income Avi to Common (ttm)	--
Diluted EPS (ttm)	--
Total Cash (mrq)	--
Total Debt/Equity (mrq)	--
Levered Free Cash Flow (ttm)	--

Sellas Life Sciences Group I (SLS)

Smart Money Signals — SLS

Buying streak — 6 quarters in a row

At the ownership peak (100% of max)

Fast accumulation — +158% more funds vs a year ago

More buyers than sellers — 71% buying

Steady new buyers — ~67 new funds per quarter

Mostly new holders — 58% entered in last year

Value +494% but shares only +53% — price-driven

Acceleration phase — new buyers rushing in

Early stage — 74% of holders entered in last year

Elite ownership — 70% AUM from top-100 funds

Institutional Sentiment Summary — SLS

Hedge Fund Ownership: SLS

Market Analysis: SLS

Analyst Price Targets

Analyst Recommendations

Stock Performance

Company Profile: SLS

Hedge Fund Positioning: SLS

Statistics: SLS

Valuation Measures Data as of: --

Financial Highlights

Institutional Holders (2026 Q2)

Frequently Asked Questions — Sellas Life Sciences Group I (SLS)

Welcome to 13Foresight!